GP incentives review ‘nothing but disrespectful’ The RACGP President lashed out at its recommended new payment architecture, saying it ignores GPs’ advice and devalues the profession.
Wegovy launches in Australia The manufacturer assured GPs supply planning has been its priority amid critical Ozempic shortages, but concerns remain over Wegovy’s availability.
Cystic fibrosis medication expanded on PBS Doctors can soon prescribe subsidised Trikafta to children earlier, in a ‘lifechanging’ move set to save families $250,000 each year.
Sweeping change needed amid ‘diabetes epidemic’: Inquiry The RACGP says prevention is key, as Medicare reform, bolstered rural access, sugar taxes, and CGM subsidies were all recommended.
GPs protest scrapped pregnancy counselling exemption The RACGP urged the Government to reverse the removal, saying it limits access to care and creates ‘reproductive healthcare deserts’.
Olaparib and anifrolumab added to PBS The treatments for breast cancer and lupus have now been added to the scheme, alongside medicines for leukaemia and insomnia.
COVID telehealth item numbers set to expire next month The Federal Government is planning to remove level C phone rebates for antiviral consultations and scrap the 12-month relationship exemption.
Government provides MyMedicare incentive clarity Practices and practitioners will soon be able to sign up for the new General Practice in Aged Care Incentive ahead of its launch on 1 August.
PBS restrictions placed on diabetes medicines GPs now need to gain additional approval prior to starting patients on all GLP-1 RAs, including semaglutide.
Study questions Paxlovid’s COVID-19 ‘usefulness’ Researchers say the antiviral does little to reduce symptom duration for some vaccinated patients, but still recommended its use for the vulnerable.